San Donato Hospital
Parkinson's disease treatment cost in Italy typically begins with complex diagnostics of Parkinson's disease ranging from $200 to $600. Standard care often involves medication treatment for Parkinson's disease costing $2,200 to $4,800, while advanced deep brain stimulation (DBS) surgery runs from $32,000 to $45,000. Total expenses depend on the disease stage and required surgical interventions. Patients often find treatments in Milan, Turin, and Rome.
Typical Parkinson's Disease Treatment Costs in Italy
Bookimed Expert Insight: For advanced motor symptoms, choosing a specialist with historical expertise provides the best results. Dr. Enrico Motti at Maria Cecilia Hospital performed Italy’s first dopaminergic cell brain implantation. Patients seeking high-tier neurological care should consider Santa Caterina da Siena in Turin. It was ranked as the best clinic for neurological disorders by Bookimed patients in 2019.
| Italy | Turkey | Austria | |
| Medication treatment for Parkinson's disease | from $2,200 | from $1,000 | from $2,000 |
| Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) | from $12,000 | from $10,000 | from $16,000 |
| Deep brain stimulation (DBS) surgery | from $32,000 | from $23,000 | from $45,000 |
| Stem cell therapy for Parkinson's disease | from $18,000 | from $25,000 | from $35,000 |
| Induced Pluripotent Stem Cells Therapy | from $32,000 | - | - |
No hidden fees – just official clinic prices. Pay at the clinic for Parkinson's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Parkinson's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Parkinson's disease treatment journey.
Dr. Motti pioneered the first brain implantation of dopaminergic cells for Parkinson's in Italy and leads Maria Cecilia Hospital's Gamma Knife Unit.
Expert in Parkinson's disease and movement disorders – Dr. Profice combines academic excellence with hands-on neurology experience at Mater Olbia Hospital.
Dr. Nicola Vione has performed thousands of procedures in functional and facial plastic surgery. He is a specialist in otorhinolaryngology at Santa Caterina da Siena clinic in Turin. Dr. Vione serves as a Professor of Functional and Aesthetic Surgery of the Nose.
Written by Kateryna Zamkovska
Italian neurosurgery centers primarily perform Deep Brain Stimulation surgery using local anesthesia with conscious sedation. This awake approach allows clinicians to monitor patient responses in real time. Surgeons at facilities like San Raffaele and Maria Cecilia Hospital also offer general anesthesia for patients with severe anxiety or tremors.
Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital demonstrate a long history of innovation, having performed the country’s first dopaminergic cell brain implantation in 1987. Dr. Enrico Motti at this clinic has over 40 years of expertise and uses JCI-accredited protocols. When selecting a facility, verify if they use 3D imaging or Gamma Knife technologies, as these specialized tools often correlate with more refined anesthesia protocols tailored to complex functional lesions.
Patient Consensus: Patients note it is helpful to prepare mentally for being conscious during the electrode testing phase. They suggest discussing light sedation options for the initial frame application to reduce anxiety before the mapping begins.
Patients undergoing bilateral deep brain stimulation in Italy typicaly stay in the hospital for 3 days. This period allows medical teams to monitor surgical leads and begin initial device programming. Surgical teams frequently use general anesthesia during the 3 to 4 hour procedure.
Bookimed Expert Insight: While hospital stays are short, Italian IRCCS-accredited centers like San Raffaele emphasize research-driven recovery protocols. Our data shows patients benefit from choosing facilities where neurologists like Dr. Enrico Motti have over 40 years of experience. High-volume centers performing 50,000+ operations annually often provide more efficient post-operative programming sessions.
Patient Consensus: Patients note that while the hospital stay is brief, staying nearby for 1 week is essential. This allows for critical medication adjustments and lead testing before traveling home.
Appropriate candidates for bilateral deep brain stimulation in Italy typically have idiopathic Parkinson's disease for at least 4 to 5 years. They must show a positive response to levodopa with a 30% motor score improvement. Candidates generally experience disabling motor fluctuations or dyskinesia despite optimal medical therapy.
Bookimed Expert Insight: Italian neurosurgery centers like Maria Cecilia Hospital or San Raffaele prioritize clinicians with extensive functional experience. Dr. Enrico Motti performed Italy's first dopaminergic cell brain implant in 1987 and manages complex functional lesions. Choosing a center with such historical expertise is vital because bilateral electrode placement requires high precision to avoid speech or cognitive side effects.
Patient Consensus: Patients note that showing a stable history of levodopa response is the most critical hurdle for approval. Many emphasize that centers in Milan and Rome may differ on whether to perform bilateral surgery at once or use a staged unilateral approach.
Post-operative recovery after deep brain stimulation typically involves a one to two night hospital stay. Patients must keep surgical incisions on the scalp and chest dry for 72 hours. Initial symptoms like headaches or fatigue usually subside as brain swelling decreases within the first month.
Bookimed Expert Insight: Italian neurosurgery centers like Maria Cecilia Hospital and San Raffaele provide high-volume expertise for complex movement disorders. Dr. Enrico Motti at Maria Cecilia Hospital has over 40 years of experience. This level of specialization is vital because precise lead placement directly impacts how quickly patients reach optimal symptom control during the first 6 months of programming.
Patient Consensus: Patients emphasize wearing button-down shirts to avoid pulling clothes over head incisions. Many recommend using ice packs for initial headaches and stocking up on waterproof dressings before returning home.
Italian hospitals offer both MR-conditional and rechargeable Deep Brain Stimulation systems for Parkinson's disease. These advanced devices allow for safe 1.5T or 3T MRI scans under specific conditions. Rechargeable models significantly outperform non-rechargeable ones in longevity, typically lasting 15 to 25 years.
Bookimed Expert Insight: Data from Italian neurosurgery hubs shows a clear shift toward high-volume research centers like San Raffaele. These institutions perform over 52,000 operations annually, providing the technical infrastructure needed for complex DBS management. Choosing these high-capacity centers often ensures access to the latest sensing-enabled stimulators like the Medtronic Percept family.
Patient Consensus: Patients note that while rechargeable systems require more weekly maintenance, the trade-off is worth it to avoid repeated surgeries. Many emphasize asking neurosurgeons directly about specific device brands, as availability often depends on regional hospital budgets.
Patients should plan for a 5 to 8 week stay in Italy for a two-stage Deep Brain Stimulation (DBS) procedure. This timeline covers mapping, electrode placement, neurostimulator implantation, and essential post-operative programming. Most international clinical protocols recommend waiting 6 weeks before long-haul air travel.
Bookimed Expert Insight: While initial estimates often suggest 2 weeks, internal data shows successful international cases require closer to 8 weeks. Specialized centers like Maria Cecilia Hospital or Mater Olbia Hospital emphasize that programming iterations are unpredictable. It is wiser to book flexible return flights to accommodate extra stabilization sessions with neurologists like Dr. Paolo Profice.
Patient Consensus: Patients note that programming the device takes much longer than the surgery itself. They emphasize bringing a caregiver and packing enough medication for a 2-month stay to avoid stress.
Milan and Rome are Italys primary hubs for high-volume Deep Brain Stimulation (DBS) programs. Leading facilities like San Raffaele and Agostino Gemelli University Policlinic hold IRCCS accreditation. These research-driven centers offer advanced neurosurgical care with high-precision technology for international Parkinson’s disease patients.
Bookimed Expert Insight: Clinical volume is the most reliable proxy for safety in Italian DBS programs. San Raffaele and Maria Cecilia Hospital stand out by performing thousands of surgeries annually. This high frequency allows these centers to maintain exceptionally high success rates. Patients should prioritize these IRCCS-accredited institutes as they integrate the latest research directly into surgical protocols.
Patient Consensus: Patients note that Milan centers like San Raffaele offer the smoothest experience for foreigners with English-speaking coordinators. Many emphasize the importance of choosing high-volume surgeons who perform at least 50 DBS procedures every year.
Italian neurosurgery centres provide Deep Brain Stimulation (DBS) and MRI-guided Focused Ultrasound (MRgFUS). These treat Parkinson’s disease. These facilities manage movement disorders using electrode implantation or non-invasive ultrasound. Specialists at JCI-accredited and IRCCS-certified hospitals provide neurological care and programming.
Bookimed Expert Insight: Many centres provide DBS. Still, choosing an IRCCS-accredited facility like San Raffaele or San Donato is a good idea. These institutions combine research with clinical practice. This often provides faster access to techniques like Induced Pluripotent Stem Cells Therapy. This environment is valuable for complex cases needing more than standard medication.
Patient Consensus: Patients note it is essential to find centres with integrated movement-disorder teams in Italy. Most emphasise that the team handling post-surgery device programming is as important as the procedure.
Australian patients can access Parkinson's disease treatment in Italy through private specialist clinics and public hospitals. Specialist centres in Milan, Rome, and Bologna offer specialised therapies. These include Deep Brain Stimulation (DBS) and MR-guided Focused Ultrasound. Australians may access urgent public care via the Reciprocal Health Care Agreement.
Bookimed Expert Insight: Many patients seek standard medication. However, Italy's true strength lies in high-volume surgical expertise. Dr Enrico Motti performed Italy's first dopaminergic cell brain implant. He now conducts over 500 Gamma Knife procedures yearly. Choosing a neurologist at IRCCS-accredited hospitals often provides earlier access to emerging Parkinson’s protocols.
Patient Consensus: Patients recommend finding a multidisciplinary movement-disorders team rather than a general neurologist. It helps to prepare English medical records before your trip. You should also arrange local follow-up in Australia before travelling to Italy.
The ReGen approach is a non-pharmacological rehabilitation program for Parkinson's disease in Boario Terme. It focuses on intensive physical therapy and lifestyle management. This multidisciplinary method aims to improve motor function and quality of life. It uses immersive sessions in a natural environment.
Bookimed Expert Insight: Italy serves as a major European research hub. Hospitals like San Raffaele perform 52,000 operations annually. Boario Terme focuses on lifestyle rehabilitation. However, surgical excellence is concentrated in Milan and Bologna. Dr Enrico Motti at Maria Cecilia Hospital performed Italy's first dopaminergic cell implantation. This highlights the country's long history in neurological innovation. Choosing between residential rehab and surgery depends on a patient's specific needs.
Patient Consensus: Not enough patient reviews available to form a consensus.International patients can join Parkinson's disease clinical trials in Italy through major research hospitals. Eligibility depends on study protocols, disease stage, and residency status. Facilities like San Raffaele in Milan and Maria Cecilia Hospital conduct research into stem cells and neurosurgery.
Bookimed Expert Insight: Italian research hospitals like San Raffaele and San Donato treat 300,000 patients annually. This volume across many departments creates more opportunities for multidisciplinary trials. Patients should focus on IRCCS-accredited facilities. The Italian Ministry of Health designates these for clinical research and hospitalisation.
Patient Consensus: Patients note that logistics like repeated scans are often the main hurdle. Successful participants recommend checking if trial sites can coordinate follow-up care with their local neurologists in Australia.
Highly-regarded Italian centres for Parkinson's disease treatment include San Raffaele and Maria Cecilia Hospital. These facilities offer deep brain stimulation and Gamma Knife radiosurgery. Italian neurology departments often hold IRCCS status. This designation confirms they combine specialist medical care with intensive clinical research.
Bookimed Expert Insight: Many Parkinson's patients seek standard medication, but Italy specialises in functional neurosurgery. Dr Enrico Motti at Maria Cecilia Hospital performed Italy's first dopaminergic cell implantation in 1987. This long history of innovation persists. Current treatments like MRgFUS offer non-invasive options for tremor management. These procedures may cost approximately A$16,600 to A$27,600. High-volume centres like San Raffaele perform over 52,000 operations annually across all specialties. This provides a deep safety net for complex neurological cases.